Masthead.
- Published in:
- Drug Development Research, 1995, v. 36, n. 2, p. fmi, doi. 10.1002/ddr.430360201
- Publication type:
- Article
Works matching IS 02724391 AND DT 1995 AND VI 36 AND IP 2
Results: 5
1
2
Antinociceptive effects of a novel dual cyclooxygenase/5-lipoxygenase inhibitor (tepoxalin) and its primary (carboxylic acid) metabolite (RWJ 20142) in acute tests in mice and rats.
- Published in:
- Drug Development Research, 1995, v. 36, n. 2, p. 81, doi. 10.1002/ddr.430360203
- By:
- Publication type:
- Article
3
Cell volume and drug action: Some interactions and perspectives.
- Published in:
- Drug Development Research, 1995, v. 36, n. 2, p. 61, doi. 10.1002/ddr.430360202
- By:
- Publication type:
- Article
4
Cellular distribution of the mRNA for the α7 subunit of the nicotinic acetylcholine receptor in the human cerebral cortex.
- Published in:
- Drug Development Research, 1995, v. 36, n. 2, p. 103, doi. 10.1002/ddr.430360205
- By:
- Publication type:
- Article
5
Inhibition of nicotine-evoked [<sup>3</sup>H] dopamine release by pyridino N-substituted nicotine analogues: A new class of nicotinic antagonist.
- Published in:
- Drug Development Research, 1995, v. 36, n. 2, p. 91, doi. 10.1002/ddr.430360204
- By:
- Publication type:
- Article